Transplantation of SIRT1-engineered aged mesenchymal stem cells improves cardiac function in a rat myocardial infarction model

Journal of Heart and Lung Transplantation

Volumn 33, Issue 10, 2014, Pages 1083-1092

  Liu, Xianbao ^a   Chen, Huiqiang ^a   Zhu, Wei ^a   Chen, Han ^a   Hu, Xinyang ^a   Jiang, Zhi ^a   Xu, Yinchuan ^a   Zhou, Yu ^a   Wang, Kan ^a   Wang, Lihan ^a   Chen, Panpan ^a   Hu, Hengxun ^a   Wang, Chen ^a   Zhang, Na ^a   Ma, Qunchao ^a   Huang, Mingyuan ^a   Hu, Dexing ^a   Zhang, Ling ^a   Wu, Rongrong ^a   Wang, Yaping ^a   Xu, Qiyuan ^a   Yu, Hong ^a   Wang, Jian'An ^a   more..

^a ZHEJIANG UNIVERSITY SCHOOL OF MEDICINE   (China)

Author keywords

cell therapy; cells aging; infarction; mesenchymal stem; myocardial; SIRT1; stem

Indexed keywords

ANGIOPOIETIN 1; BASIC FIBROBLAST GROWTH FACTOR RECEPTOR; LACTATE DEHYDROGENASE; PROTEIN BAX; PROTEIN BCL 2; SIRTUIN 1; THROMBOSPONDIN 1; ANGIOGENIN; BIOLOGICAL MARKER; FIBROBLAST GROWTH FACTOR 2; PANCREATIC RIBONUCLEASE; SIRT1 PROTEIN, RAT;

ANGIOGENESIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; CELL AGING; CELL SURVIVAL; CONTROLLED STUDY; CORONARY ARTERY LIGATION; FEMALE; HEART FUNCTION; HEART HEMODYNAMICS; HEART INFARCTION; HEART INFARCTION SIZE; HEART LEFT VENTRICLE ENDDIASTOLIC PRESSURE; HEART PERFORMANCE; IN VITRO STUDY; IN VIVO STUDY; LEFT ANTERIOR DESCENDING CORONARY ARTERY; MALE; MESENCHYMAL STEM CELL TRANSPLANTATION; NONHUMAN; PHENOTYPE; PROTEIN EXPRESSION; RAT; SRY GENE; THORAX SURGERY; TRANSTHORACIC ECHOCARDIOGRAPHY; UPREGULATION; ANIMAL; BIOLOGICAL THERAPY; CELL CULTURE; DISEASE MODEL; ECHOCARDIOGRAPHY; HEART; HEMODYNAMICS; METABOLISM; MYOCARDIAL INFARCTION; PATHOPHYSIOLOGY; PHYSIOLOGY; PROCEDURES; SPRAGUE DAWLEY RAT; TREATMENT OUTCOME;

ANIMALS; BIOMARKERS; CELL AGING; CELL- AND TISSUE-BASED THERAPY; CELLS, CULTURED; DISEASE MODELS, ANIMAL; ECHOCARDIOGRAPHY; FEMALE; FIBROBLAST GROWTH FACTOR 2; HEART; HEMODYNAMICS; MALE; MESENCHYMAL STEM CELL TRANSPLANTATION; MYOCARDIAL INFARCTION; PHENOTYPE; RATS; RATS, SPRAGUE-DAWLEY; RIBONUCLEASE, PANCREATIC; SIRTUIN 1; TREATMENT OUTCOME; UP-REGULATION;

EID: 84908121302     PISSN: 10532498     EISSN: 15573117     Source Type: Journal    
DOI: 10.1016/j.healun.2014.05.008     Document Type: Article

References (42)

1. J.S. Lee, J.M. Hong, and G.J. Moon A long-term follow-up study of intravenous autologous mesenchymal stem cell transplantation in patients with ischemic stroke Stem Cells 28 2010 1099 1106
2. A.R. Williams, and J.M. Hare Mesenchymal stem cells biology, pathophysiology, translational findings, and therapeutic implications for cardiac disease Circ Res 109 2011 923 940
3. P. Connick, M. Kolappan, and C. Crawley Autologous mesenchymal stem cells for the treatment of secondary progressive multiple sclerosis: an open-label phase 2a proof-of-concept study Lancet Neurol 11 2012 150 156
4. A.S. Go, D. Mozaffarian, and V.L. Roger Heart disease and stroke statistics-2013 update a report from the American Heart Association Circulation 127 2013 e6 245
5. S. Jiang, H. Kh Haider, and R.P. Ahmed Transcriptional profiling of young and old mesenchymal stem cells in response to oxygen deprivation and reparability of the infarcted myocardium J Mol Cell Cardiol 44 2008 582 596
6. M. Khan, S. Mohsin, and S.N. Khan Repair of senescent myocardium by mesenchymal stem cells is dependent on the age of donor mice J Cell Mol Med 15 2011 1515 1527
7. T.S. Li, M. Kubo, and K. Ueda Impaired angiogenic potency of bone marrow cells from patients with advanced age, anemia, and renal failure J Thorac Cardiovasc Surg 139 2010 459 465
8. J.M. Yu, X. Wu, and J.M. Gimble Age-related changes in mesenchymal stem cells derived from rhesus macaque bone marrow Aging Cell 10 2011 66 79
9. A. Stolzing, and A. Scutt Age-related impairment of mesenchymal progenitor cell function Aging Cell 5 2006 213 224
10. O. Katsara, L.G. Mahaira, and E.G. Iliopoulou Effects of donor age, gender, and in vitro cellular aging on the phenotypic, functional, and molecular characteristics of mouse bone marrow-derived mesenchymal stem cells Stem Cells Dev 20 2011 1549 1561
11. A. Efimenko, E. Starostina, and N. Kalinina Angiogenic properties of aged adipose derived mesenchymal stem cells after hypoxic conditioning J Transl Med 9 2011 10
12. A. Stolzing, E. Jones, and D. McGonagle Age-related changes in human bone marrow-derived mesenchymal stem cells: consequences for cell therapies Mech Ageing Devel 129 2008 163 173
13. S. Zhou, J.S. Greenberger, and M.W. Epperly Age-related intrinsic changes in human bone-marrow-derived mesenchymal stem cells and their differentiation to osteoblasts Aging Cell 7 2008 335 343
14. J.M. Hare, J.E. Fishman, and G. Gerstenblith Comparison of allogeneic vs autologous bone marrow-derived mesenchymal stem cells delivered by transendocardial injection in patients with ischemic cardiomyopathy. The POSEIDON Randomized Trial. Mesenchymal Stem Cells and Ischemic Cardiomyopathy JAMA 308 2012 2369 2379
15. S. Dhingra, X.P. Huang, and R.K. Li Challenges in allogeneic mesenchymal stem cell-mediated cardiac repair Trends Cardiovasc Med 20 2010 263 268
16. K. Maiese, Z.Z. Chong, and Y.C. Shang Translating cell survival and cell longevity into treatment strategies with SIRT1 Rom J Morphol Embryol 52 2011 1173
17. C.M. Bäckesjö, Y. Li, and U. Lindgren Activation of Sirt1 decreases adipocyte formation during osteoblast differentiation of mesenchymal stem cells J Bone Miner Res 21 2006 993 1002
18. P. Simic, K. Zainabadi, and E. Bell SIRT1 regulates differentiation of mesenchymal stem cells by deacetylating β-catenin EMBO Mol Med 5 2013 430 440
19. H.F. Yuan, C. Zhai, and X.L. Yan SIRT1 is required for long-term growth of human mesenchymal stem cells J Mol Med 90 2012 389 400
20. A. Scutt, and P. Bertram Bone marrow cells are targets for the anabolic actions of prostaglandin E2 on bone: induction of a transition from nonadherent to adherent osteoblast precursors J Bone Miner Res 10 1995 474 487
21. U. Galderisi, H. Helmbold, and T. Squillaro In vitro senescence of rat mesenchymal stem cells is accompanied by downregulation of stemness-related and DNA damage repair genes Stem Cells Dev 18 2009 1033 1042
22. M.I. Niagara, H.K. Haider, and S. Jiang Pharmacologically preconditioned skeletal myoblasts are resistant to oxidative stress and promote angiomyogenesis via release of paracrine factors in the infarcted heart Circ Res 100 2007 545 555
23. Z. Jiang, X. Hu, and H. Yu Human endometrial stem cells confer enhanced myocardial salvage and regeneration by paracrine mechanisms J Cell Mol Med 17 2013 1247 1260
24. J. An, N. Beauchemin, and J. Albanese Use of a rat cDNA probe specific for the Y chromosome to detect male-derived cells J Androl 18 1997 289 293
25. S.W. Peng, X.Y. Guo, and G.G. Shang An assessment of the risks of carcinogenicity associated with polyhydroxyalkanoates through an analysis of DNA aneuploid and telomerase activity Biomaterials 32 2011 2546 2555
26. J. Pons, Y. Huang, and J. Takagawa Combining angiogenic gene and stem cell therapies for myocardial infarction J Gene Med 11 2009 743 753
27. W. Chang, B.W. Song, and S. Lim Mesenchymal stem cells pretreated with delivered Hph-1-Hsp70 protein are protected from hypoxia-mediated cell death and rescue heart functions from myocardial injury Stem Cells 27 2009 2283 2292
28. X. Wang, T. Zhao, and W. Huang Hsp20-engineered mesenchymal stem cells are resistant to oxidative stress via enhanced activation of Akt and increased secretion of growth factors Stem Cells 27 2009 3021 3031
29. E.U. Alt, C. Senst, and S.N. Murthy Aging alters tissue resident mesenchymal stem cell properties Stem Cell Res 8 2012 215 225
30. J. Campisi Aging, cellular senescence, and cancer Ann Rev Physiol 75 2013 685 705
31. Z. Pasha, Y. Wang, and R. Sheikh Preconditioning enhances cell survival and differentiation of stem cells during transplantation in infarcted myocardium Cardiovasc Res 77 2008 134 142
32. M.S. Choudhery, M. Khan, and R. Mahmood Mesenchymal stem cells conditioned with glucose depletion augments their ability to repair-infarcted myocardium J Cell Mol Med 16 2012 2518 2529
33. S.R. Spindler Caloric restriction: from soup to nuts Ageing Res Rev 9 2010 324 353
34. H. Liang, H. Hou, and W. Yi Increased expression of pigment epithelium-derived factor in aged mesenchymal stem cells impairs their therapeutic efficacy for attenuating myocardial infarction injury Eur Heart J 34 2013 1681 1690
35. A. Rosenow, J.P. Noben, and J. Jocken Resveratrol-induced changes of the human adipocyte secretion profile J Proteome Res 11 2012 4733 4743
36. L. da Silva Meirelles, A.M. Fontes, and D.T. Covas Mechanisms involved in the therapeutic properties of mesenchymal stem cells Cytokine Growth Factor Rev 20 2009 419 427
37. R. Menghini, V. Casagrande, and M. Cardellini MicroRNA 217 modulates endothelial cell senescence via silent information regulator 1 Circulation 120 2009 1524 1532
38. T. Zhao, J. Li, and A.F. Chen MicroRNA-34a induces endothelial progenitor cell senescence and impedes its angiogenesis via suppressing silent information regulator 1 Am J Physiol Endocrinol Metabol 299 2010 E110 E116
39. W. Li, N. Ma, and L.L. Ong Bcl-2 engineered MSCs inhibited apoptosis and improved heart function Stem Cells 25 2007 2118 2127
40. R.S. Khan, Z. Fonseca-Kelly, and C. Callinan SIRT1 activating compounds reduce oxidative stress and prevent cell death in neuronal cells Front Cell Neurosci 6 2012 63
41. W. He, Y. Wang, and M.Z. Zhang Sirt1 activation protects the mouse renal medulla from oxidative injury J Clin Invest 120 2010 1056
42. Z. Zhang, S. Li, and M. Cui Rosuvastatin enhances the therapeutic efficacy of adipose-derived mesenchymal stem cells for myocardial infarction via PI3K/Akt and MEK/ERK pathways Basic Res Cardiol 108 2013 1 18